Dr. Petros Grivas, MD at Cleveland Clinic discusses the correlation of myeloid derived suppressor cell (MDSC) populations with clinicopathologic features in urothelial carcinoma (UC) at ASCO GU 2016
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content